Chronic Inflammation Potentiates Kidney Aging

Seminars in Nephrology

Volumn 29, Issue 6, 2009, Pages 555-568

  Mei, Changlin ^a   Zheng, Feng ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; inflammation; kidney aging

Indexed keywords

ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CD40 LIGAND; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CYSTATIN C; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIRTUIN 6; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AGING; ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; DNA DAMAGE; ENDOPLASMIC RETICULUM STRESS; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATORY INFILTRATE; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FAILURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENESCENCE;

AGING; ANIMALS; CHRONIC DISEASE; FEMALE; HUMANS; INFLAMMATION; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; MALE; MICE; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 71849111963     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2009.07.002     Document Type: Article

References (100)

1. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
3. Baylis C. Changes in renal hemodynamics and structure in the aging kidney; sexual dimorphism and the nitric oxide system. Exp Gerontol 40 (2005) 271-278
4. Cai W., He J.C., Zhu L., Chen X., Zheng F., Striker G.E., et al. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol 173 (2008) 327-336
5. Melk A., Schmidt B.M., Braun H., Vongwiwatana A., Urmson J., Zhu L.F., et al. Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant 9 (2009) 114-123
6. Cesari M., Penninx B.W., Pahor M., Lauretani F., Corsi A.M., Rhys W.G., et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 59 (2004) 242-248
7. Uribarri J., Cai W., Peppa M., Goodman S., Ferrucci L., Striker G., et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 62 (2007) 427-433
8. Krabbe K.S., Pedersen M., and Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 39 (2004) 687-699
9. Silverstein D.M. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol 24 (2009) 1445-1452
10. Stinghen A.E., Goncalves S.M., Martines E.G., Nakao L.S., Riella M.C., Aita C.A., et al. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease. Nephron Clin Pract 111 (2009) c117-c126
11. Costa E., Lima M., Alves J.M., Rocha S., Rocha-Pereira P., Castro E., et al. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol 28 (2008) 268-275
12. Pecoits-Filho R., Heimburger O., Barany P., Suliman M., Fehrman-Ekholm I., Lindholm B., et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 41 (2003) 1212-1218
13. Keller C.R., Odden M.C., Fried L.F., Newman A.B., Angleman S., Green C.A., et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 71 (2007) 239-244
14. Dorshkind K., Montecino-Rodriguez E., and Signer R.A. The ageing immune system: is it ever too old to become young again?. Nat Rev Immunol 9 (2009) 57-62
15. Wu D., and Meydani S.N. Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J Leukoc Biol 84 (2008) 900-914
16. Min H., Montecino-Rodriguez E., and Dorshkind K. Effects of aging on the common lymphoid progenitor to pro-B cell transition. J Immunol 176 (2006) 1007-1012
17. Frasca D., Landin A.M., Lechner S.C., Ryan J.G., Schwartz R., Riley R.L., et al. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 180 (2008) 5283-5290
18. Huang M.C., Liao J.J., Bonasera S., Longo D.L., and Goetzl E.J. Nuclear factor-kappaB-dependent reversal of aging-induced alterations in T cell cytokines. FASEB J 22 (2008) 2142-2150
19. Dixit V.D. Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J Leukoc Biol 84 (2008) 882-892
20. Wu D., Ren Z., Pae M., Guo W., Cui X., Merrill A.H., et al. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. J Immunol 179 (2007) 4829-4839
21. Guilherme A., Virbasius J.V., Puri V., and Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9 (2008) 367-377
22. Rodwell G.E., Sonu R., Zahn J.M., Lund J., Wilhelmy J., Wang L., et al. A transcriptional profile of aging in the human kidney. PLoS Biol 2 (2004) e427
23. Zheng F., Cheng Q.L., Plati A.R., Ye S.Q., Berho M., Banerjee A., et al. The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration. Am J Pathol 165 (2004) 1789-1798
24. Zheng F., Plati A.R., Potier M., Schulman Y., Berho M., Banerjee A., et al. Resistance to glomerulosclerosis in B6 mice disappears after menopause. Am J Pathol 162 (2003) 1339-1348
25. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 25 (1961) 585-621
26. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92 (1995) 9363-9367
27. Chen Q., Fischer A., Reagan J.D., Yan L.J., and Ames B.N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A 92 (1995) 4337-4341
28. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 11 (2009) 59-98
29. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
30. Herbig U., Jobling W.A., Chen B.P., Chen D.J., and Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14 (2004) 501-513
31. Krishnamurthy J., Torrice C., Ramsey M.R., Kovalev G.I., Al Regaiey K., Su L., et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114 (2004) 1299-1307
32. Martin G.M. Genetic modulation of senescent phenotypes in Homo sapiens. Cell 120 (2005) 523-532
33. Salk D., Bryant E., Au K., Hoehn H., and Martin G.M. Systematic growth studies, cocultivation, and cell hybridization studies of Werner syndrome cultured skin fibroblasts. Hum Genet 58 (1981) 310-316
34. Kuilman T., and Peeper D.S. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 9 (2009) 81-94
35. Meng T.C., Fukada T., and Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9 (2002) 387-399
36. Sundaresan M., Yu Z.X., Ferrans V.J., Irani K., and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
37. Chen K., Kirber M.T., Xiao H., Yang Y., and Keaney Jr. J.F. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 181 (2008) 1129-1139
38. Baud V., and Karin M. Is NF-kappaB a good target for cancer therapy?. Hopes and pitfalls. Nat Rev Drug Discov 8 (2009) 33-40
39. Sanguino E., Roglans N., Rodriguez-Calvo R., Alegret M., Sanchez R.M., Vazquez-Carrera M., et al. Ageing introduces a complex pattern of changes in several rat brain transcription factors depending on gender and anatomical localization. Exp Gerontol 41 (2006) 372-379
40. Jung K.J., Go E.K., Kim J.Y., Yu B.P., and Chung H.Y. Suppression of age-related renal changes in NF-kappaB and its target gene expression by dietary ferulate. J Nutr Biochem 20 (2009) 378-388
41. Go E.K., Jung K.J., Kim J.Y., Yu B.P., and Chung H.Y. Betaine suppresses proinflammatory signaling during aging: the involvement of nuclear factor-kappaB via nuclear factor-inducing kinase/IkappaB kinase and mitogen-activated protein kinases. J Gerontol A Biol Sci Med Sci 60 (2005) 1252-1264
42. Lees S.J., Zwetsloot K.A., and Booth F.W. Muscle precursor cells isolated from aged rats exhibit an increased tumor necrosis factor α. Aging Cell 8 (2009) 26-35
43. Ivory K., Martin R., and Hughes D.A. Significant presence of terminally differentiated T cells and altered NF-kappaB and I-kappaBalpha interactions in healthy ageing. Exp Gerontol 39 (2004) 567-576
44. Schreck R., Albermann K., and Baeuerle P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17 (1992) 221-237
45. Li N., and Karin M. Is NF-kappaB the sensor of oxidative stress?. FASEB J 13 (1999) 1137-1143
46. Hayakawa M., Miyashita H., Sakamoto I., Kitagawa M., Tanaka H., Yasuda H., et al. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22 (2003) 3356-3366
47. Matsuzawa A., Tseng P.H., Vallabhapurapu S., Luo J.L., Zhang W., Wang H., et al. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321 (2008) 663-668
48. Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoyiannis D., Stamatakis K., Lin J.H., et al. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103 (2000) 1071-1083
49. Han Z., Boyle D.L., Chang L., Bennett B., Karin M., Yang L., et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108 (2001) 73-81
50. Lin A., Minden A., Martinetto H., Claret F.X., Lange-Carter C., Mercurio F., et al. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268 (1995) 286-290
51. Ventura J.J., Kennedy N.J., Lamb J.A., Flavell R.A., and Davis R.J. c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol Cell Biol 23 (2003) 2871-2882
52. Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.L., Naugler W., et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 6 (2007) 386-397
53. Han J., Lee J.D., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 (1994) 808-1
54. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2 (2001) 222-228
55. Fujino G., Noguchi T., Matsuzawa A., Yamauchi S., Saitoh M., Takeda K., et al. Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1. Mol Cell Biol 27 (2007) 8152-8163
56. Matsuzawa A., Saegusa K., Noguchi T., Sadamitsu C., Nishitoh H., Nagai S., et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 6 (2005) 587-592
57. Iriyama T., Takeda K., Nakamura H., Morimoto Y., Kuroiwa T., Mizukami J., et al. ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis. EMBO J 28 (2009) 843-853
58. Minamino T., Yujiri T., Papst P.J., Chan E.D., Johnson G.L., and Terada N. MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes. Proc Natl Acad Sci U S A 96 (1999) 15127-15132
59. Gallagher E., Enzler T., Matsuzawa A., Anzelon-Mills A., Otero D., Holzer R., et al. Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production. Nat Immunol 8 (2007) 57-63
60. Farooq A., and Zhou M.M. Structure and regulation of MAPK phosphatases. Cell Signal 16 (2004) 769-779
61. Zhao Q., Wang X., Nelin L.D., Yao Y., Matta R., Manson M.E., et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 203 (2006) 131-140
62. Zhang Y., Blattman J.N., Kennedy N.J., Duong J., Nguyen T., Wang Y., et al. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature 430 (2004) 793-797
63. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
64. Hou N., Torii S., Saito N., Hosaka M., and Takeuchi T. Reactive oxygen species-mediated pancreatic beta-cell death is regulated by interactions between stress-activated protein kinases, p38 and c-Jun N-terminal kinase, and mitogen-activated protein kinase phosphatases. Endocrinology 149 (2008) 1654-1665
65. Chan D.W., Liu V.W., Tsao G.S., Yao K.M., Furukawa T., Chan K.K., et al. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 29 (2008) 1742-1750
66. Kim H.J., Jung K.J., Yu B.P., Cho C.G., and Chung H.Y. Influence of aging and calorie restriction on MAPKs activity in rat kidney. Exp Gerontol 37 (2002) 1041-1053
67. Abidi P., Leers-Sucheta S., Cortez Y., Han J., and Azhar S. Evidence that age-related changes in p38 MAP kinase contribute to the decreased steroid production by the adrenocortical cells from old rats. Aging Cell 7 (2008) 168-178
68. Ron D., and Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8 (2007) 519-529
69. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 (2004) 457-461
70. Kaser A., Lee A.H., Franke A., Glickman J.N., Zeissig S., Tilg H., et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134 (2008) 743-756
71. Lindenmeyer M.T., Rastaldi M.P., Ikehata M., Neusser M.A., Kretzler M., Cohen C.D., et al. Proteinuria and hyperglycemia induce endoplasmic reticulum stress. J Am Soc Nephrol 19 (2008) 2225-2236
72. Yokouchi M., Hiramatsu N., Hayakawa K., Kasai A., Takano Y., Yao J., et al. Atypical, bidirectional regulation of cadmium-induced apoptosis via distinct signaling of unfolded protein response. Cell Death Differ 14 (2007) 1467-1474
73. Yokouchi M., Hiramatsu N., Hayakawa K., Okamura M., Du S., Kasai A., et al. Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response. J Biol Chem 283 (2008) 4252-4260
74. Deng J., Lu P.D., Zhang Y., Scheuner D., Kaufman R.J., Sonenberg N., et al. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol 24 (2004) 10161-10168
75. Urano F., Wang X., Bertolotti A., Zhang Y., Chung P., Harding H.P., et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287 (2000) 664-666
76. Zhang K., Shen X., Wu J., Sakaki K., Saunders T., Rutkowski D.T., et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124 (2006) 587-599
77. Todd D.J., Lee A.H., and Glimcher L.H. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 8 (2008) 663-674
78. Vlassara H., and Striker G. Glycotoxins in the diet promote diabetes and diabetic complications. Curr Diab Rep 7 (2007) 235-241
79. Thornalley P.J. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease. Drug Metabol Drug Interact 23 (2008) 125-150
80. Du X., Matsumura T., Edelstein D., Rossetti L., Zsengeller Z., Szabo C., et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112 (2003) 1049-1057
81. Kilhovd B.K., Giardino I., Torjesen P.A., Birkeland K.I., Berg T.J., Thornalley P.J., et al. Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism 52 (2003) 163-167
82. Li Y.M., Steffes M., Donnelly T., Liu C., Fuh H., Basgen J., et al. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci U S A 93 (1996) 3902-3907
83. Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Du Y.S., et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274 (1999) 31740-31749
84. Yan S.F., Ramasamy R., and Schmidt A.M. The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease. Expert Rev Mol Med 11 (2009) e9
85. Park L., Raman K.G., Lee K.J., Lu Y., Ferran Jr. L.J., Chow W.S., et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4 (1998) 1025-1031
86. Harja E., Bu D.X., Hudson B.I., Chang J.S., Shen X., Hallam K., et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest 118 (2008) 183-194
87. Schmidt A.M., Yan S.D., Yan S.F., and Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108 (2001) 949-955
88. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97 (1999) 889-901
89. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8 (2007) 487-496
90. Venkatachalam K., Venkatesan B., Valente A.J., Melby P.C., Nandish S., Reusch J.E., et al. Wisp1, a pro-mitogenic, pro-survival factor, mediates TNF-alpha stimulated cardiac fibroblast proliferation, but inhibits TNF-alpha-induced cardiomyocyte death. J Biol Chem 284 (2009) 14414-14427
91. Lai K.N., Leung J.C., Chan L.Y., Saleem M.A., Mathieson P.W., Tam K.Y., et al. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 24 (2009) 62-72
92. Jakubzick C., Kunkel S.L., Puri R.K., and Hogaboam C.M. Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis. Immunol Res 30 (2004) 339-349
93. Zheng F., Plati A.R., Banerjee A., Elliot S., Striker L.J., and Striker G.E. The molecular basis of age-related kidney disease. Sci Aging Knowledge Environ 2003 (2003) E20
94. Jinde K., Nikolic-Paterson D.J., Huang X.R., Sakai H., Kurokawa K., Atkins R.C., et al. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38 (2001) 761-769
95. Li Y., Kang Y.S., Dai C., Kiss L.P., Wen X., and Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172 (2008) 299-308
96. Acosta J.C., O'Loghlen A., Banito A., Guijarro M.V., Augert A., Raguz S., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133 (2008) 1006-1018
97. Melk A. Senescence of renal cells: molecular basis and clinical implications. Nephrol Dial Transplant 18 (2003) 2474-2478
98. Bishop N.A., and Guarente L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet 8 (2007) 835-844
99. Kawahara T.L., Michishita E., Adler A.S., Damian M., Berber E., Lin M., et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136 (2009) 62-74
100. Mostoslavsky R., Chua K.F., Lombard D.B., Pang W.W., Fischer M.R., Gellon L., et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124 (2006) 315-329